Rate My Professor Dianqing Wu

Wu's laboratory employs molecular, cell biological, biochemical, chemical biological, transgenic, functional genomic, and proteomic approaches to elucidate mechanisms including those linked by PLCβ, PI3Kγ, PIXα/Pak/Cdc42, PTEN, P-Rex1, and Myo1f. Key discoveries include the interaction between Wnt coreceptor LRP-5 and Axin, establishing the first connection from Wnt receptor to intracellular signaling, and the role of Dkk2 in regulating osteogenic differentiation. He developed an antibody that blocks tumors in animal models of colorectal cancer and holds four U.S. patents. Wu has authored 73 publications amassing over 7,800 citations, including recent works such as "Cell surface RNAs control neutrophil recruitment" (Cell, 2024), "Wnt5 controls splenic myelopoiesis and neutrophil functional ambivalency during DSS-induced colitis" (Cell Reports, 2024), and "LDL receptor-related protein 5 selectively transports unesterified polyunsaturated fatty acids to intracellular compartments" (Nature Communications, 2024). He serves on editorial boards of the Journal of Biological Chemistry, Cell Research, and Current Genomics, and is a member of the American Association for the Advancement of Science, American Society of Biochemistry and Molecular Biology, and American Society of Cell Biology. Wu received the Outstanding Investigator Award from the National Heart, Lung, and Blood Institute.